GMP细胞银行服务市场:各细胞类型，各终端用户，各地区-市场规模，占有率，展望，机会分析，2023年～2030年

市场动态

扩大采用无机增长战略，例如市场主要参与者进行收购以扩大其产品组合，预计将在预测期内推动市场增长。

为了扩大产品系列，市场主要企业采用设施扩张等内部成长策略的案例增多，也将促进在预测期间内的市场成长。

本调查的主要特征

• 本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球GMP细胞银行服务市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
• 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
• 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
• 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球GMP细胞银行服务市场的主要参与者之企业简介。
• 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 全球GMP细胞银行服务市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以透过全球GMP细胞银行服务市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

• 调查目的
• 前提条件
• 简称

第2章 市场展望

• 报告概要
  • 市场定义和范围
• 摘要整理
• 连贯·机遇·地图(COM)

第3章 市场动态，法规，趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 市场魅力分析
  • 市场机会
• 产品上市
• 合併，收购，联盟
• 法规指南和遵守
• 主要的发展
• PEST分析
• 技术形势
• 波特分析
• 价格分析(2022年)

第4章 全球GMP细胞银行服务市场-COVID-19影响分析

• 经济影响
• COVID-19流行病学
• 供需的影响

第5章 GMP细胞银行服务的全球市场:各细胞类型，2018年-2030年

• 哺乳类
• 微生物
• 昆虫
• 酵母
• 鸟类
• 干细胞类型
• 其他

第6章 GMP细胞银行服务的全球市场:各终端用户，2018年～2030年

• 生物医药品企业
• CMO

第7章 GMP细胞银行服务的全球市场:各地区，2018年～2030年

• 北美
• 美国
• 加拿大
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他南美国家
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 中国
• 印度
• 日本
• ASEAN
• 澳洲
• 韩国
• 其他亚太地区
• 中东
• GCC
• 以色列
• 其他中东
• 非洲
• 北非
• 中非
• 南非

第8章 竞争情形

• WuXi AppTec Group
• Charles River Laboratories International, Inc.
• Eurofins Scientific
• Merck KGaA
• Lonza Group Ltd.
• SGS Ltd.
• ViruSure GmbH
• Austrianova
• Goodwin Biotechnology Inc.
• Paragon Bioservices, Inc.

第9章 章节

• 调查手法
• 关于出版社

Cell banking systems are set up to assure that a uniform population of cells is preserved, their integrity is maintained, and a sufficient supply of material is accessible for the life of the product. Biosafety testing is performed on cell lines at multiple passages.

Cell banking provides a characterized, common starting source for each manufactured lot of product, and assures that an adequate supply of equivalent cells exist for use during the entire lifespan of the product

Market Dynamics

Increasing adoption of inorganic growth strategies, such as acquisition by key players in the market to expand their product portfolio, is expected to drive market growth over the forecast period. For instance, in June 2021, Generate Life Sciences, a life sciences company, announced that it has acquired the Cell Care Group, an international cord blood banking group that comprises cell care in Australia. Cell Care joins Generate's Cord Blood Registry in creating a global network of newborn stem cell (umbilical cord blood and tissue) banks from which to further their collective regenerative medicine research, while also providing Canadian and Australian families with greater access to reproductive and genetic services that help grow and protect healthy families from preconception into adulthood

The increasing adoption of organic growth strategies such as facility expansion by key players in the market to expand their product portfolio is expected to drive market growth over the forecast period. For instance, on April 6, 2023, Avid Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced the completion of two expansions within the company's mammalian cell facilities. The newly expanded manufacturing capacity includes both upstream and downstream CGMP manufacturing suites and serves as a complement to Avid's existing Myford facility, providing increased capacity to address the needs of both existing and future mammalian cell business customers

Key features of the study:

• This report provides in-depth analysis of the global GMP cell banking services market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global GMP cell banking services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study WuXi AppTec Group, Charles River Laboratories International, Inc., Eurofins Scientific, Merck KGaA, Lonza Group Ltd., SGS Ltd., ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., and Paragon Bioservices, Inc.
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global GMP cell banking services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP cell banking services market

Detailed Segmentation:

• Global GMP Cell Banking Services Market, By Cell Type:
  • Mammalian
  • Microbial
  • Insect
  • Yeast
  • Avian
  • Stem Cell Type
  • Others
• Global GMP Cell Banking Services Market, By End User:
  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
• Global GMP Cell Banking Services Market, By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles
  • WuXi AppTec Group*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Charles River Laboratories International, Inc.,
  • Eurofins Scientific
  • Merck KGaA
  • Lonza Group Ltd.
  • SGS Ltd.
  • ViruSure GmbH
  • Austrianova
  • Goodwin Biotechnology Inc.
  • Paragon Bioservices, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market PurviewS

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Cell Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
• Product Launches
• Merger, Acquisition, Collaborations
• Regulatory Guideline and Compliances
• Key Developments
• PEST Analysis
• Technology Landscape
• PORTER's Analysis
• Pricing Analysis (2022)

4. Global GMP Cell Banking Services Market- COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global GMP Cell Banking Services Market, By Cell Type, 2018 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Mammalian
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Microbial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Insect
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Yeast
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Avian
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Stem Cell Type
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global GMP Cell Banking Services Market, By End User, 2018 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
• Contract Manufacturing Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global GMP Cell Banking Services Market, By Region, 2018 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

8. Competitive Landscape

• WuXi AppTec Group*
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Charles River Laboratories International, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Eurofins Scientific
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Lonza Group Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• SGS Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ViruSure GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Austrianova
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Goodwin Biotechnology Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Paragon Bioservices, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• Research Methodology
• About Us